HealthTech Agents

Cite as: Real Problem AI problem “My employer is dropping Zepbound and Wegovy coverage in 2027, what are my options?”. Opportunity score 7.6 out of 10 (severity 8, AI feasibility 7, market signal 9, competition gap 6). Category HealthTech. Trend Agents. Source signal: r/Zepbound post "How many insurance plans actually KEEPING coverage for 2027?", 20 October 2026, 328 comments.. Canonical URL: https://www.realproblem.ai/idea/my-employer-is-dropping-zepbound-and-wegovy-coverage-in-2027-what-are-my-options.

My employer is dropping Zepbound and Wegovy coverage in 2027, what are my options?

Employers and insurers are removing GLP-1 weight loss coverage for 2027, even for people already in maintenance or with sleep apnea or heart indications, leaving them to choose between self-pay, appeals, compounding or stopping.

Who has it: Employees on employer health plans taking Zepbound or Wegovy for weight loss, their prescribers, and HR benefits teams answering the questions.

Heard in public

“We have been informed that no weight loss medications will be covered as of January 1, even if they are prescribed under one of the other FDA approvals like sleep apnea or heart health.”

Quoted word for word from the public post linked below. Nobody submitted it to Real Problem AI.

r/Zepbound post "How many insurance plans actually KEEPING coverage for 2027?", 20 October 2026, 328 comments.

What nothing does yet

A coverage loss planner that reads the 2027 formulary, checks whether a covered indication (sleep apnea, cardiovascular) or exception applies, drafts the appeal for the prescriber, and compares the true yearly cost of every self-pay route.

Tools that solve this

4 named so far, and where each one stops.

  • LillyDirect and NovoCare self-pay

    Lower cash prices from the makers, but still hundreds of dollars a month.

  • Manufacturer savings cards and GoodRx

    Often require commercial coverage of the drug, so they stop working once it is excluded.

  • Compounding telehealth

    Cheaper, but legal status and supply are under pressure.

  • Prescriber appeals and prior authorization

    Manual, plan specific, and rarely tried for the other approved indications.

How you might build it

  1. 01Formulary and plan document parsing
  2. 02Appeal and prior authorization letter generator
  3. 03Cash price comparison data
  4. 04Prescriber portal export
  5. 05LLM explainer

#NOV32 · Canonical URL: https://www.realproblem.ai/idea/my-employer-is-dropping-zepbound-and-wegovy-coverage-in-2027-what-are-my-options